Top Story

FDA approves Rapivab for treatment of influenza in adults

December 22, 2014

The FDA has approved the IV drug peramivir for the treatment of influenza in adults, according to a press release.

Peramivir (Rapivab, BioCryst Pharmaceuticals), a neuraminidase inhibitor, is indicated for patients aged 18 years or older with acute uncomplicated influenza who have been symptomatic for no more than 2 days.

HDV inhibitor receives orphan drug designation by FDA, EMA

December 22, 2014
Eiger BioPharmaceuticals Inc. has been granted orphan drug designation by the FDA and European Medicines Agency for its drug lonafarnib for the treatment of hepatitis…
Edward Cox FDA approvals

FDA approves Zerbaxa for complicated intra-abdominal infections, UTIs

December 22, 2014
The FDA has approved a new combination antibiotic for the treatment of complicated intra-abdominal infections and complicated urinary tract infections in…
In the Journals

PEG-IFN monotherapy reduced HBsAg expression

December 22, 2014
Patients with hepatitis B virus infection who underwent monotherapy with pegylated interferon had decreased hepatitis B surface antigen expression and an increased rate…

Mothers with probable, confirmed Ebola should not breast-feed

December 22, 2014
The Association of Women’s Health, Obstetric and Neonatal Nurses recently published recommendations for the management of pregnant women with Ebola.Patients with…
More News Headlines »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
Meeting News Coverage Video
thumbnail for video 3911388507001

Student education, immunization requirements necessary to prevent outbreaks on college campuses

November 28, 2014
NEW YORK — James C. Turner, MD, executive director of the department of student health and the National Social…
More »
CME
J490 Challenges in HIV Screening

Challenges in HIV Screening and Prophylaxis: PrEP’ing for the Future

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

A substantial proportion of Americans with HIV remain undiagnosed and suboptimally treated. Failure to follow…
More »
morganatic-roan
morganatic-roan